HIV Diagnostics Market Report

HIV Diagnostics Market Analysis By Product (Antibody Tests, Viral Identification Assays, CD4 Testing, Viral Load Testing, Early Infant Diagnosis) And Segment Forecasts To 2022

  • Published Date: Jan, 2016
  • Base Year for Estimate: 2015
  • Report ID: 978-1-68038-461-1
  • Format: Electronic (PDF)
  • Historical Data: 2013-2015
  • Number of Pages: 121

Table of Content

Chapter 1. Methodology and Scope
                  1.1. Research Methodology
                  1.2. Research Scope & Assumption
                  1.3. List of Data Sources
Chapter 2. Executive Summary
                  2.1. HIV Diagnostics - Industry Snapshot and Key Buying Criteria, 2014
Chapter 3. HIV Diagnostics Industry Outlook
                  3.1. Market Segmentation
                  3.2. Market size and growth prospects
                  3.3. HIV Diagnostics Market dynamics
                     3.3.1. Market Driver Analysis
                          3.3.1.1. Growing prevalence of HIV
                          3.3.1.2. Introduction of rapid and portable diagnostic tests
                          3.3.1.3. Implementation of favorable government initiatives
                     3.3.2. Market Restraint Analysis
                          3.3.2.1. Low market penetration in emerging and underdeveloped economies
                  3.4. Industry Analysis - Porter’s
                  3.5. Key opportunities prioritized
                  3.6. HIV Diagnostics market - PESTEL analysis
                  3.7. HIV diagnostics unmet needs analysis
                  3.8. HIV diagnostics company market share analysis, 2014
Chapter 4. HIV Diagnostics Product Outlook
                  4.1. HIV Diagnostics Market Share By Product, 2014 & 2022
                  4.2. Antibody Tests
                     4.2.1. Antibody Tests Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                     4.2.2. HIV-1 Screening Tests Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                          4.2.2.1. ELISA/EIA
                          4.2.2.2. Home Access Dried Blood Spot
                          4.2.2.3. Rapid Tests
                     4.2.3. HIV-1 Confirmatory Tests Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                          4.2.3.1. Western Blot Test
                          4.2.3.2. Indirect Immunoflourescent Antibody Assay (IFA)
                          4.2.3.3. Line ImmunoAssay (Cnf)
                          4.2.3.4. RadioImmuno-Precipitation (RIPA)
                     4.2.4. HIV-2 & Group O Diagnostic Tests Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                          4.2.4.1. Blood Antibody Tests
                          4.2.4.2. DBS Tests
                          4.2.4.3. Line ImmunoAssay (HIV2)
                  4.3. Viral Identification Tests
                     4.3.1. Viral Identification Tests Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                          4.3.1.1. p24 Antigen Test
                          4.3.1.2. Qualitative PCR Tests
                          4.3.1.3. Viral Culture
                  4.4. CD4 Testing
                     4.4.1. CD4 Testing Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                  4.5. Viral Load testing
                     4.5.1. Viral load Testing Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                  4.6. Early Infant Diagnostics
                     4.6.1. Early Infant Diagnostics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
Chapter 5. HIV Diagnostics Regional Outlook
                  5.1. HIV Diagnostics Market Share By Region, 2014 & 2022
                  5.2. North America
                     5.2.1. Market Estimates and Forecasts, by Product, 2012 - 2022 (USD Million)
                          5.2.1.1. U.S. Market Estimates and Forecasts
                          5.2.1.2. Canada Market Estimates and Forecasts
                  5.3. Europe
                     5.3.1. Europe HIV Diagnostics Market Estimates and Forecasts, by Product, 2012 - 2022 (USD Million)
                          5.3.1.1. Germany Market Estimates and Forecasts
                          5.3.1.2. UK Market Estimates and Forecasts
                  5.4. Asia Pacific
                     5.4.1. Market Estimates and Forecasts, by Product, 2012 - 2022 (USD Million)
                          5.4.1.1. China Market Estimates and Forecasts
                          5.4.1.2. Japan Market Estimates and Forecasts
                  5.5. Latin America
                     5.5.1. Market Estimates and Forecasts, by Product, 2012 - 2022 (USD Million)
                          5.5.1.1. Brazil Market Estimates and Forecasts
                  5.6. MEA
                     5.6.1. MEA HIV Diagnostics Market Estimates and Forecasts, by Product, 2012 - 2022 (USD Million)
                          5.6.1.1. South Africa Market Estimates and Forecasts
Chapter 6. Competitive Landscape
                  6.1. Alere Inc.
                     6.1.1. Company Overview
                     6.1.2. Financial Performance
                     6.1.3. Product Benchmarking
                     6.1.4. Strategic Initiative
                  6.2. Beckman Coulter
                     6.2.1. Company Overview
                     6.2.2. Financial Performance
                     6.2.3. Product Benchmarking
                     6.2.4. Strategic Initiative
                  6.3. BD Biosciences
                     6.3.1. Company Overview
                     6.3.2. Financial Performance
                     6.3.3. Product Benchmarking
                     6.3.4. Strategic Initiative
                  6.4. VIIV Healthcare
                     6.4.1. Company Overview
                     6.4.2. Financial Performance
                     6.4.3. Product Benchmarking
                     6.4.4. Strategic Initiative
                  6.5. Merch & Co. Inc.
                     6.5.1. Company Overview
                     6.5.2. Financial Performance
                     6.5.3. Product Benchmarking
                     6.5.4. Strategic Initiative
                  6.6. Gilead Sciences
                     6.6.1. Company Overview
                     6.6.2. Financial Performance
                     6.6.3. Product Benchmarking
                     6.6.4. Strategic Initiative
                  6.7. Janssen Therapeutics
                     6.7.1. Company Overview
                     6.7.2. Financial Performance
                     6.7.3. Product Benchmarking
                     6.7.4. Strategic Initiative
                  6.8. Bristol-Myers Squibb
                     6.8.1. Company Overview
                     6.8.2. Financial Performance
                     6.8.3. Product Benchmarking
                     6.8.4. Strategic Initiative
                  6.9. Abbvie Inc.
                     6.9.1. Company Overview
                     6.9.2. Financial Performance
                     6.9.3. Product Benchmarking
                     6.9.4. Strategic Initiative
                  6.10. Abbott Healthcare
                     6.10.1. Company Overview
                     6.10.2. Financial Performance
                     6.10.3. Product Benchmarking
                     6.10.4. Strategic Initiative
                  6.11. Partec
                     6.11.1. Company Overview
                     6.11.2. Financial Performance
                     6.11.3. Product Benchmarking
                     6.11.4. Strategic Initiative
                  6.12. Sysmex
                     6.12.1. Company Overview
                     6.12.2. Financial Performance
                     6.12.3. Product Benchmarking
                     6.12.4. Strategic Initiative
                  6.13. Apogee Flow Systems
                     6.13.1. Company Overview
                     6.13.2. Financial Performance
                     6.13.3. Product Benchmarking
                     6.13.4. Strategic Initiative
                  6.14. PointCare Technologies Inc.
                     6.14.1. Company Overview
                     6.14.2. Financial Performance
                     6.14.3. Product Benchmarking
                     6.14.4. Strategic Initiative
                  6.15. Zyomyx Inc.
                     6.15.1. Company Overview
                     6.15.2. Financial Performance
                     6.15.3. Product Benchmarking
                     6.15.4. Strategic Initiative
                  6.16. Mylan Inc.
                     6.16.1. Company Overview
                     6.16.2. Financial Performance
                     6.16.3. Product Benchmarking
                     6.16.4. Strategic Initiative
                  6.17. Roche Diagnostics
                     6.17.1. Company Overview
                     6.17.2. Financial Performance
                     6.17.3. Product Benchmarking
                     6.17.4. Strategic Initiative
                  6.18. Siemens Healthcare
                     6.18.1. Company Overview
                     6.18.2. Financial Performance
                     6.18.3. Product Benchmarking
                     6.18.4. Strategic Initiative
                  6.19. Siemens Healthcare
                     6.19.1. Company Overview
                     6.19.2. Financial Performance
                     6.19.3. Product Benchmarking
                     6.19.4. Strategic Initiative
                  6.20. Siemens Healthcare
                     6.20.1. Company Overview
                     6.20.2. Financial Performance
                     6.20.3. Product Benchmarking
                     6.20.4. Strategic Initiative


List of Tables

1. HIV Diagnostics Market - Industry Summary & Key Buying Criteria, 2012 - 2022
2. HIV Diagnostics market, by product, 2012 - 2022 (USD Million)
3. HIV Diagnostics - Key market driver analysis
4. HIV Diagnostics - Key market restraint analysis
5. North America HIV Diagnostics market, by product, 2012 - 2022 (USD Million)
6. U.S. HIV Diagnostics market, by product, 2012 - 2022 (USD Million)
7. Canada HIV Diagnostics market, by product, 2012 - 2022 (USD Million)
8. Europe HIV Diagnostics market, by product, 2012 - 2022 (USD Million)
9. Germany HIV Diagnostics market, by product, 2012 - 2022 (USD Million)
10. UK HIV Diagnostics market, by product, 2012 - 2022 (USD Million)
11. Asia Pacific HIV Diagnostics market, by product, 2012 - 2022 (USD Million)
12. Japan HIV Diagnostics market, by product, 2012 - 2022 (USD Million)
13. China HIV Diagnostics market, by product, 2012 - 2022 (USD Million)
14. Latin America HIV Diagnostics market, by product, 2012 - 2022 (USD Million)
15. Brazil HIV Diagnostics market, by product, 2012 - 2022 (USD Million)
16. MEA HIV Diagnostics market, by product, 2012 - 2022 (USD Million)
17. South Africa HIV Diagnostics market, by product, 2012 - 2022 (USD Million)


List of Figures

1. HIV Diagnostics: Market segmentation
2. Global HIV Diagnostics market, 2012 - 2022 (USD Million)
3. HIV Diagnostics: Market dynamics
4. HIV Diagnostics market - Porter’s Analysis
5. Key opportunities prioritized 2014
6. HIV Diagnostics market - PESTEL analysis
7. HIV Diagnostics: Company market share analysis, 2014
8. HIV Diagnostics market share, by product, 2014 & 2022
9. Global HLA testing market, 2012 - 2022 (USD Million)
10. Global antibody screening tests market, 2012 - 2022 (USD Million)
11. Global HIV-1 screening tests market, 2012 - 2022 (USD Million)
12. Global HIV-1 confirmatory tests market, 2012 - 2022 (USD Million)
13. Global HIV-2 & Group O diagnostic tests market, 2012 - 2022 (USD Million)
14. Global viral identification assays market, 2012 - 2022 (USD Million)
15. North America HIV Diagnostics market, 2012 - 2022 (USD Million)
16. North America HIV-1 screening tests market, 2012 - 2022 (USD Million)
17. North America HIV-1 confirmatory tests market, 2012 - 2022 (USD Million)
18. North America HIV-2 & Group O diagnostic tests market, 2012 - 2022 (USD Million)
19. North America viral identification assays market, 2012 - 2022 (USD Million)
20. U.S. HIV Diagnostics market, 2012 - 2022 (USD Million)
21. U.S. HIV-1 screening tests market, 2012 - 2022 (USD Million)
22. U.S. HIV-1 confirmatory tests market, 2012 - 2022 (USD Million)
23. U.S. HIV-2 & Group O diagnostic tests market, 2012 - 2022 (USD Million)
24. U.S. viral identification assays market, 2012 - 2022 (USD Million)
25. Canada HIV Diagnostics market, 2012 - 2022 (USD Million)
26. Canada HIV-1 screening tests market, 2012 - 2022 (USD Million)
27. Canada HIV-1 confirmatory tests market, 2012 - 2022 (USD Million)
28. Canada HIV-2 & Group O diagnostic tests market, 2012 - 2022 (USD Million)
29. Canada viral identification assays market, 2012 - 2022 (USD Million)
30. Europe HIV Diagnostics market, 2012 - 2022 (USD Million)
31. Europe HIV-1 screening tests market, 2012 - 2022 (USD Million)
32. Europe HIV-1 confirmatory tests market, 2012 - 2022 (USD Million)
33. Europe HIV-2 & Group O diagnostic tests market, 2012 - 2022 (USD Million)
34. Europe viral identification assays market, 2012 - 2022 (USD Million)
35. Germany HIV Diagnostics market, 2012 - 2022 (USD Million)
36. Germany HIV-1 screening tests market, 2012 - 2022 (USD Million)
37. Germany HIV-1 confirmatory tests market, 2012 - 2022 (USD Million)
38. Germany HIV-2 & Group O diagnostic tests market, 2012 - 2022 (USD Million)
39. Germany viral identification assays market, 2012 - 2022 (USD Million)
40. UK HIV Diagnostics market, 2012 - 2022 (USD Million)
41. UK HIV-1 screening tests market, 2012 - 2022 (USD Million)
42. UK HIV-1 confirmatory tests market, 2012 - 2022 (USD Million)
43. UK HIV-2 & Group O diagnostic tests market, 2012 - 2022 (USD Million)
44. UK viral identification assays market, 2012 - 2022 (USD Million)
45. Asia Pacific HIV Diagnostics market, 2012 - 2022 (USD Million)
46. Asia Pacific HIV-1 screening tests market, 2012 - 2022 (USD Million)
47. Asia Pacific HIV-1 confirmatory tests market, 2012 - 2022 (USD Million)
48. Asia Pacific HIV-2 & Group O diagnostic tests market, 2012 - 2022 (USD Million)
49. Asia Pacific viral identification assays market, 2012 - 2022 (USD Million)
50. Japan HIV Diagnostics market, 2012 - 2022 (USD Million)
51. Japan HIV-1 screening tests market, 2012 - 2022 (USD Million)
52. Japan HIV-1 confirmatory tests market, 2012 - 2022 (USD Million)
53. Japan HIV-2 & Group O diagnostic tests market, 2012 - 2022 (USD Million)
54. Japan viral identification assays market, 2012 - 2022 (USD Million)
55. China HIV Diagnostics market, 2012 - 2022 (USD Million)
56. China HIV-1 screening tests market, 2012 - 2022 (USD Million)
57. China HIV-1 confirmatory tests market, 2012 - 2022 (USD Million)
58. China HIV-2 & Group O diagnostic tests market, 2012 - 2022 (USD Million)
59. China viral identification assays market, 2012 - 2022 (USD Million)
60. Latin America HIV Diagnostics market, 2012 - 2022 (USD Million)
61. Latin America HIV-1 screening tests market, 2012 - 2022 (USD Million)
62. Latin America HIV-1 confirmatory tests market, 2012 - 2022 (USD Million)
63. Latin America HIV-2 & Group O diagnostic tests market, 2012 - 2022 (USD Million)
64. Latin America viral identification assays market, 2012 - 2022 (USD Million)
65. Brazil HIV Diagnostics market, 2012 - 2022 (USD Million)
66. Brazil HIV-1 screening tests market, 2012 - 2022 (USD Million)
67. Brazil HIV-1 confirmatory tests market, 2012 - 2022 (USD Million)
68. Brazil HIV-2 & Group O diagnostic tests market, 2012 - 2022 (USD Million)
69. Brazil viral identification assays market, 2012 - 2022 (USD Million)
70. MEA HIV Diagnostics market, 2012 - 2022 (USD Million)
71. MEA HIV-1 screening tests market, 2012 - 2022 (USD Million)
72. MEA HIV-1 confirmatory tests market, 2012 - 2022 (USD Million)
73. MEA HIV-2 & Group O diagnostic tests market, 2012 - 2022 (USD Million)
74. MEA viral identification assays market, 2012 - 2022 (USD Million)
75. South Africa HIV Diagnostics market, 2012 - 2022 (USD Million)
76. South Africa HIV-1 screening tests market, 2012 - 2022 (USD Million)
77. South Africa HIV-1 confirmatory tests market, 2012 - 2022 (USD Million)
78. South Africa HIV-2 & Group O diagnostic tests market, 2012 - 2022 (USD Million)
79. South Africa viral identification assays market, 2012 - 2022 (USD Million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.